A citation-based method for searching scientific literature


List of co-cited articles
150 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
Tian Huanna, Zuo Tao, Wang Xiangfei, An Longfei, Xie Yuanyuan, Wang Jianhua, Zhang Cuifang, Jiao Manjing, Cao Wenjing, Qin Shaochuan,[...]. Mol Carcinog 2015
42
46

Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
Eric P Bennett, Ulla Mandel, Henrik Clausen, Thomas A Gerken, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2012
437
42

Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
Jae-Hyun Park, Toshihiko Nishidate, Kyoko Kijima, Takao Ohashi, Kaoru Takegawa, Tomoko Fujikane, Koichi Hirata, Yusuke Nakamura, Toyomasa Katagiri. Cancer Res 2010
117
42

Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival.
Z Li, S Yamada, S Inenaga, T Imamura, Y Wu, K-Y Wang, S Shimajiri, R Nakano, H Izumi, K Kohno,[...]. Br J Cancer 2011
55
38

Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
Jae-Hyun Park, Toyomasa Katagiri, Suyoun Chung, Kyoko Kijima, Yusuke Nakamura. Neoplasia 2011
72
38

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
Klaus W Wagner, Elizabeth A Punnoose, Thomas Januario, David A Lawrence, Robert M Pitti, Kate Lancaster, Dori Lee, Melissa von Goetz, Sharon Fong Yee, Klara Totpal,[...]. Nat Med 2007
426
34

Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas.
S Kitada, S Yamada, A Kuma, S Ouchi, T Tasaki, A Nabeshima, H Noguchi, K-Y Wang, S Shimajiri, R Nakano,[...]. Br J Cancer 2013
50
26

All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.
Kelly G Ten Hagen, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2003
337
26

Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
Zhi-Qiang Wang, Magdalena Bachvarova, Chantale Morin, Marie Plante, Jean Gregoire, Marie-Claude Renaud, Alexandra Sebastianelli, Dimcho Bachvarov. Oncotarget 2014
59
26

Mucins in cancer: protection and control of the cell surface.
Michael A Hollingsworth, Benjamin J Swanson. Nat Rev Cancer 2004
23

GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
Mei-Chun Lin, Miao-Juei Huang, Chiung-Hui Liu, Tsung-Lin Yang, Min-Chuan Huang. Oral Oncol 2014
52
23

Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
Yao-Ming Wu, Chiung-Hui Liu, Rey-Heng Hu, Miao-Juei Huang, Jian-Jr Lee, Chi-Hau Chen, John Huang, Hong-Shiee Lai, Po-Huang Lee, Wen-Ming Hsu,[...]. Cancer Res 2011
71
19



N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers.
H Dosaka-Akita, I Kinoshita, K Yamazaki, H Izumi, T Itoh, H Katoh, M Nishimura, K Matsuo, Y Yamada, K Kohno. Br J Cancer 2002
34
19

N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.
Chen Wu, Xiaodan Guo, Weina Wang, Yun Wang, Yaojun Shan, Bo Zhang, Wenqian Song, Sisi Ma, Jianfeng Ge, Hao Deng,[...]. BMC Cancer 2010
45
19

Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process.
Leonardo Freire-de-Lima, Kirill Gelfenbeyn, Yao Ding, Ulla Mandel, Henrik Clausen, Kazuko Handa, Sen-Itiroh Hakomori. Proc Natl Acad Sci U S A 2011
83
19

Glycosylation in cancer: mechanisms and clinical implications.
Salomé S Pinho, Celso A Reis. Nat Rev Cancer 2015
19

Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.
Jean-Charles Soria, Zsuzsanna Márk, Petr Zatloukal, Barna Szima, István Albert, Erzsébet Juhász, Jean-Louis Pujol, Jerzy Kozielski, Nigel Baker, Dominic Smethurst,[...]. J Clin Oncol 2011
172
19

GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma.
Yidong Liu, Weisi Liu, Le Xu, Haiou Liu, Weijuan Zhang, Yu Zhu, Jiejie Xu, Jianxin Gu. J Urol 2014
9
55

A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma.
Chau-Ting Yeh, Kung-Hao Liang, Chen-Chun Lin, Ming-Ling Chang, Cheng-Lung Hsu, Chien-Fu Hung. Int J Cancer 2014
18
27

GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.
Wey-Ran Lin, Jy-Ming Chiang, Kung-Hao Liang, Siew-Na Lim, Ming-Wei Lai, Yung-Kuan Tsou, Tzu-Yun Hsieh, Chih-Kai Hsu, Chau-Ting Yeh. Medicine (Baltimore) 2016
10
50

Prognostic significance of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-3 (GalNAc-T3) expression in patients with gastric carcinoma.
Koji Onitsuka, Kazunori Shibao, Yoshifumi Nakayama, Noritaka Minagawa, Keiji Hirata, Hiroto Izumi, Ken-ichi Matsuo, Naoki Nagata, Kenji Kitazato, Kimitoshi Kohno,[...]. Cancer Sci 2003
31
15

Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma.
Joana Gomes, Nuno T Marcos, Nora Berois, Eduardo Osinaga, Ana Magalhães, João Pinto-de-Sousa, Raquel Almeida, Fátima Gärtner, Celso A Reis. J Histochem Cytochem 2009
43
15

miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.
Avital Gaziel-Sovran, Miguel F Segura, Raffaella Di Micco, Mary K Collins, Douglas Hanniford, Eleazar Vega-Saenz de Miera, John F Rakus, John F Dankert, Shulian Shang, Robert S Kerbel,[...]. Cancer Cell 2011
254
15

Antibody-based assay for N-deacetylase activity of heparan sulfate/heparin N-deacetylase/N-sulfotransferase (NDST): novel characteristics of NDST-1 and -2.
Jacob van den Born, Dagmar Sandback Pikas, Brenda J M Pisa, Inger Eriksson, Lena Kjellen, Jo H M Berden. Glycobiology 2003
64
15

GALNT9 gene expression is a prognostic marker in neuroblastoma patients.
Nora Berois, Charles-Henry Gattolliat, Enrique Barrios, Laura Capandeguy, Sétha Douc-Rasy, Dominique Valteau-Couanet, Jean Bénard, Eduardo Osinaga. Clin Chem 2013
32
15

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
15

Glycosylation defining cancer malignancy: new wine in an old bottle.
Senitiroh Hakomori. Proc Natl Acad Sci U S A 2002
705
15

The sweet and sour of cancer: glycans as novel therapeutic targets.
Mark M Fuster, Jeffrey D Esko. Nat Rev Cancer 2005
878
15

UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.
Nora Berois, Daniel Mazal, Luis Ubillos, Felipe Trajtenberg, André Nicolas, Xavier Sastre-Garau, Henri Magdelenat, Eduardo Osinaga. J Histochem Cytochem 2006
56
15



Identification of GALNT14 as a novel neuroblastoma predisposition gene.
Marilena De Mariano, Roberta Gallesio, Marco Chierici, Cesare Furlanello, Massimo Conte, Alberto Garaventa, Michela Croce, Silvano Ferrini, Gian Paolo Tonini, Luca Longo. Oncotarget 2015
27
15

ppGalNAc T1 as a potential novel marker for human bladder cancer.
Ming-Xia Ding, Hai-Feng Wang, Jian-Song Wang, Hui Zhan, Yi-Gang Zuo, De-Lin Yang, Jing-Yu Liu, Wei Wang, Chang-Xing Ke, Ru-Ping Yan. Asian Pac J Cancer Prev 2012
17
17

Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular metastasis-associated behavior in gastric cancer.
Dong Hua, Li Shen, Lan Xu, Zhi Jiang, Yinghui Zhou, Aihuan Yue, Shitao Zou, Zhihong Cheng, Shiliang Wu. Int J Mol Med 2012
24
12

Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance.
Li Wang, Jie Ma, Fenghua Liu, Qingkai Yu, Guangmin Chu, Alan C Perkins, Yong Li. Gynecol Oncol 2007
49
11

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.
Ralph J DeBerardinis, Julian J Lum, Georgia Hatzivassiliou, Craig B Thompson. Cell Metab 2008
11

O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer.
F Vavasseur, K Dole, J Yang, K L Matta, N Myerscough, A Corfield, C Paraskeva, I Brockhausen. Eur J Biochem 1994
115
11

The Tn antigen-structural simplicity and biological complexity.
Tongzhong Ju, Vivianne I Otto, Richard D Cummings. Angew Chem Int Ed Engl 2011
199
11


Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.
Rebecca Siegel, Elizabeth Ward, Otis Brawley, Ahmedin Jemal. CA Cancer J Clin 2011
11

GALNT14 genotype, α-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma.
Wey-Ran Lin, Chao-Wei Hsu, Yi-Cheng Chen, Ming-Ling Chang, Kung-Hao Liang, Ya-Hui Huang, Chau-Ting Yeh. Mol Clin Oncol 2014
10
30

Mucin-type O-glycosylation and its potential use in drug and vaccine development.
Mads Agervig Tarp, Henrik Clausen. Biochim Biophys Acta 2008
207
11

Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling.
Miao-Juei Huang, Rey-Heng Hu, Chih-Hsing Chou, Chia-Lang Hsu, Ya-Wen Liu, John Huang, Ji-Shiang Hung, I-Rue Lai, Hsueh-Fen Juan, Sung-Liang Yu,[...]. Oncotarget 2015
26
11

GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.
Wan-Ling Ho, Chih-Hsing Chou, Yung-Ming Jeng, Meng-Yao Lu, Yung-Li Yang, Shiann-Tarng Jou, Dong-Tsamn Lin, Hsiu-Hao Chang, Kai-Hsin Lin, Wen-Ming Hsu,[...]. Oncotarget 2014
24
12

Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab.
Howard M Stern, Mary Padilla, Klaus Wagner, Lukas Amler, Avi Ashkenazi. Clin Cancer Res 2010
29
11

Mucin 13: structure, function, and potential roles in cancer pathogenesis.
Diane M Maher, Brij K Gupta, Satoshi Nagata, Meena Jaggi, Subhash C Chauhan. Mol Cancer Res 2011
48
11

Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown.
Yunus Emre Tarhan, Taigo Kato, Miran Jang, Yoshimi Haga, Koji Ueda, Yusuke Nakamura, Jae-Hyun Park. Neoplasia 2016
25
12

Protein glycosylation in cancer.
Sean R Stowell, Tongzhong Ju, Richard D Cummings. Annu Rev Pathol 2015
339
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.